HIM
EBS icon

Hermes Investment Management’s Emergent Biosolutions EBS Stock Holding History

Hermes Investment Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$6.54M Buy
129,542
+13,163
+11% +$686K 0.09% 138
2018
Q1 		$6.13M Buy
116,379
+70,766
+155% +$3.53M 0.09% 139
2017
Q4 		$2.12M Buy
+45,613
New +$1.92M 0.03% 151

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Hermes Investment Management's EBS Position: Q2 2018 in Review

Hermes Investment Management increased its Emergent Biosolutions (EBS) stake by 11% in Q2 2018, buying an estimated $686K and bringing the position to 129,542 shares worth $6.54M. The position accounts for 0.09% of the portfolio, ranked #138.

Hermes Investment Management first reported a position in EBS in Q4 2017 and has held it in 3 quarters since. 263 funds tracked by Wall St. Rank hold EBS as of Q2 2018.

  • Hermes Investment Management held 129,542 shares of Emergent Biosolutions worth $6.54M as of Q2 2018.
  • Hermes Investment Management bought 13,163 Emergent Biosolutions shares in Q2 2018, an estimated $686K.
  • Emergent Biosolutions made up 0.09% of Hermes Investment Management's portfolio in Q2 2018, its #138 holding.
  • Hermes Investment Management first reported a position in Emergent Biosolutions in Q4 2017 and has held it in 3 quarters since.
  • 263 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2018.

Based on Hermes Investment Management's 13F filing for Q2 2018, filed 24 Jul 2018.